TAK-117 (MLN1117)

MLN1117 · Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-117 (MLN1117), covering 2018-02-07 to 2018-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 1, Phase 2]

See pricing